Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Qin%2C+Shuxia%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Qin%2C+Shuxia%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Qin%2C+Shuxia%22&type=Person&sort=year
PubPharm (46)
1
First-Line Systemic Treatment Strategies for unresectable hepatocellular carcinoma : a cost-effectiveness analysis
enthalten in:
bioRxiv.org
| 2024
von
wang, L.
|
Peng, Y.
|
Qin, S.
| +5
Wird geladen...
2
Personalizing age of gastric cancer screening based on comorbidity in China : Model estimates of benefits, affordability and cost-effectiveness optimization
enthalten in:
Preventive medicine
| 2024
von
Qin, S.
|
Wang, X.
|
Li, S.
| +2
Wird geladen...
3
Cost-effectiveness of Trastuzumab Deruxtecan for HER2-low Advanced Breast Cancer in the United States
enthalten in:
Clinical therapeutics
| 2023
von
Peng, Y.
|
Wang, L.
|
Peng, L.
| +8
Wird geladen...
4
Estimated projection of incidence and mortality of alcohol-related liver disease in China from 2022 to 2040 : a modeling study
enthalten in:
BMC medicine
| 2023
von
Wu, M.
|
Qin, S.
|
Tan, C.
| +3
Wird geladen...
5
Estimated projection of incidence and mortality of alcohol-related liver disease in China from 2022 to 2040: a modeling study
enthalten in:
BMC medicine
| 2023
von
Wu, M.
|
Qin, S.
|
Tan, C.
| +3
Wird geladen...
6
Estimated projection of incidence and mortality of alcohol-related liver disease in China from 2022 to 2040: a modeling study
enthalten in:
BMC medicine
| 2023
von
Wu, M.
|
Qin, S.
|
Tan, C.
| +3
Wird geladen...
7
Trametinib for patients with recurrent low-grade serous ovarian cancer : A cost-effectiveness analysis
enthalten in:
Gynecologic oncology
| 2023
von
Piao, H.
|
Wu, M.
|
Qin, S.
| +4
Wird geladen...
8
First-line systemic treatment strategies for unresectable hepatocellular carcinoma : A cost-effectiveness analysis
enthalten in:
PloS one
| 2023
von
Wang, L.
|
Peng, Y.
|
Qin, S.
| +5
Wird geladen...
9
Clinical Benefit and Cost Effectiveness of Risk-Stratified Gastric Cancer Screening Strategies in China : A Modeling Study
enthalten in:
PharmacoEconomics
| 2022
von
Qin, S.
|
Wang, X.
|
Li, S.
| +9
Wird geladen...
10
Clinical Benefit and Cost Effectiveness of Risk-Stratified Gastric Cancer Screening Strategies in China: A Modeling Study
enthalten in:
PharmacoEconomics
| 2022
von
Qin, S.
|
Wang, X.
|
Li, S.
| +9
Wird geladen...
1
2
3
4
5
Nächster »
[5]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
46
Aufsätze
38
E-Artikel
38
E-Ressourcen
8
Gedruckte Aufsätze
Zeitschriftentitel
24
Advances in therapy
4
Clinical rheumatology
4
PharmacoEconomics
3
BMC medicine
3
Frontiers in pharmacology
1
Clinical therapeutics
1
Frontiers in Pharmacology
1
Frontiers in oncology
1
Frontiers in public health
1
Gynecologic oncology
1
PloS one
1
Preventive medicine
1
bioRxiv.org
Alle anzeigen ...
weniger ...
Thema
26
Cost-effectiveness
18
Markov model
17
Journal Article
12
Research Support, Non-U.S. Gov't
8
Atezolizumab
8
Non-small cell lung cancer
8
Urothelial carcinoma
5
cost-effectiveness
4
Antibodies, Monoclonal, Humanized
4
Avelumab
4
Bladder cancer
4
Cemiplimab
4
Etanercept
4
Lung cancer
4
Model
4
Nivolumab
4
PD-L1
4
Rheumatoid arthritis
4
Tofacitinib
3
Alcohol-related liver disease
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2
2024
6
2023
9
2022
29
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
46
Englisch
Haven't found what you're looking for?
Wird geladen...